|
Mouse monoclonal to human Filamin A [4E10-1B2]: IgG
|
|
|
|
mouse NGF 2.5S (99%)
|
|
|
|
mouse NGF 2.5S (>95%)
|
|
|
|
Mouse P-selectin (sP-selectin)/ GMP-140/LECAM3/PADGEM/CD62P ELISA Kit (2 plates)
|
|
|
|
mouse proBDNF
|
|
|
|
Mouse polyclonal antibody to human LMX-1.2: whole serum
|
|
|
|
Mouse Thrombopoietin/TPO/Megakaryocyte growth and development factor/MGDF ELISA Kit (2 plates)
|
|
|
|
Mouse Vascular endothelial growth factor A/VEGF-A/VEGF-164/VEGF-1/VEGF-120/VEGF-2 ELISA Kit (1 plate)
|
|
|
|
MPO, Mouse, mAb 8F4, FITC, 100 ug
|
|
|
|
MouseExoPure? 0.4 micron Immunobeads (Overall Exosome Isolation, mouse biofluids, 10 reactions)
|
|
|
|
MPO, Human, pAb, 20 ug
|
|
|
|
MPO, Human, pAb, 100 ug
|
|
|
|
MSCGro-Mesenchymal Stem Cell, complete, SF
|
|
|
|
MSCGro-Humanized Mesenchymal Stem Cell, complete
|
|
|
|
MSCGro-Mesenchymal Stem Cell complete, LS
|
|
|
|
MSCGro-Humanized Mesenchymal Stem Cell Clinical Grade Medium, SF
|
|
|
|
MsrB2 Protein aa: 42-182 (6xHis-tag)
|
|
|
|
Muscle Specific nAChR Antagonist Explorer Kit
|
|
|
|
N desulphated reN Acetylayted heparin oligosaccharides dp12
|
|
|
|
N-(S)-alpha-Hydroxytetracosanoyl-D-erythro-sphingosine
|
|
|
|
N-(32-Linoleoyloxy-dotriacontanoyl)-sphingosine-D9
|
|
|
|
Myosin S1 Fragment (Skeletal muscle), Bovine
|
|
|
|
N6-benzyladenosine | Cytokinin ELISA quantitation kit
|
|
|
|
Myosin Cardiac Muscle
|
|
|
|
N-(R)-alpha-Hydroxytetracosanoyl-D-erythro-sphingosine
|
|
|
|
Mycoplasma TaqMan PCR Kit
|
|
|
|
Myogenin (Myogenic Factor 4)/MYOG
|
|
|
|
N-(30-Linoleoyloxy-triacontanoyl)-phytosphingosine
|
|
|
|
N, N', N', N', N', N', N', N', N' Octaacetyl chitooctaose
|
|
|
|
N desulphated heparin oligosaccharides dp12
|
|
|
|
N-(R)-alpha-Hydroxytetracosanoyl-D-erythro-dihydrosphingosine
|
|
|
|
N desulphated reN Acetylayted heparin oligosaccharides dp10
|
|
|
|
N-(S)-alpha-Hydroxytetracosanoyl-phytosphingosine
|
|
|
|
N-(R)-alpha-Hydroxytetracosanoyl-phytosphingosine
|
|
|
|
N-1-13C-Hexadecanoyl-D-erythro-sphingosylphosphorylcholine
|
|
|
|
N-Acetyl-D-Glucosamine: N-Acetylglucosaminide (Peracetate)
|
|
|
|
N-Acetylgalactosamine Ligand: β-GalNAc-PEG3-DBCO
|
|
|
|
N-Acetylgalactosamine Ligand: α-GalNAc-PEG5000-Thiol
|
|
|
|
N-Acetylgalactosamine Ligand: β-GalNAc-PEG3-Alkyne
|
|
|
|
N-Acetyl-1-13C-L-cysteine-1-13C 99 atom % 13C, 97% (CP)
|
|
|
|
N-Acetylgalactosamine Ligand: α-GalNAc-PEG4-Acid
|
|
|
|
N-Acetyl-Asp-Glu-OH-15N2 98 atom % 15N, 95% (CP)
|
|
|
|
NALCN/VGCNL1 Blocking Peptide
|
|
|
|
NativePCBStockSolution
|
|
|
|
NbActiv1
|
|
|
|
Native Human Fibroblasts
|
|
|
|
NativePCBSolution/MixtureforMSDetection
|
|
|
|
Native Human Osteoblasts
|
|
|
|
NativePBBSolution/Mixture
|
|
|
|
Native Human Chondrocytes-HCS
|
|
|
|
NCX3/SLC8A3 Blocking Peptide
|
|
|
|
NdhB | NAD(P)H-quinone oxidoreductase subunit 2 (chloroplastic)
|
|
|
|
NdhH | NAD(P)H-quinone oxidoreductase subunit H (chloroplastic)
|
|
|
|
Negative control for Luminex based anti-HLA serology
|
|
|
|
Nectin-3, Mouse, mAb 103-A1, FITC, 100 ug
|
|
|
|
Neurofibrillary Tangles
|
|
|
|
Newcastle Disease Vaccine (Inactivated) WHO International Standard
|
|
|
|
n-Fect
|
|
|
|
Neurofilament NF-H, phosphylated
|
|
|
|
N-Glycinated galactosylsphingosine
|
|
|
|
NGS Normalization 96-Well Kit
|
|
|
|
N-Glycinated lyso-sulfatide
|
|
|
|
NGS Library Quantification Kit (for Small RNA-Seq)
|
|
|
|
NGFR/p75ECD Rapid ELISA Kit: Human (1 Plate)
|
|
|
|
NGAL, Human, mAb 697, 100 ug
|
|
|
|
N-Hexadecanoyl-D9 (13,13,14,14,15,15,16,16,16)-monosialoganglioside GM3 (NH4+ salt)
|
|
|
|
N-Hexadecanoyl-D9 (13,13,14,14,15,15,16,16,16)-monosialoganglioside GM1 (NH4+ salt)
|
|
|
|
N-Hexadecanoyl-D-erythro-sphingosine (C16 sphingolipid base)
|
|
|
|
N-Hexanoyl-biotin-monosialoganglioside GM3 (NH4+ salt)
|
|
|
|
N-Hexanoyl-biotin-phytosphingosine
|
|
|
|
N-Hexadecanoyl-D9 (13,13,14,14,15,15,16,16,16)-monosialoganglioside GM2 (NH4+ salt)
|
|
|
|
NHERF1/ EBP50 Blocking Peptide
|
|
|
|
N-Hexanoyl-biotin-D-erythro-dihydrosphingosine
|
|
|
|
N-Hexadecanoyl-D9 (13,13,14,14,15,15,16,16,16)-ceramide trihexoside
|
|
|
|
Nicotinic Acetylcholine Receptor alpha7/CHRNA7 B
|
|
|
|
Nicotinic acetylcholine receptor alpha7
|
|
|
|
NMDAR2A/GluN2A (extracellular) Blocking Peptide
|
|
|
|
N-methyl-d3-perfluoro-1-octanesulfonamide
|
|
|
|
N-omega-CD3-Octadecanoyl-D-erythro-dihydrosphingosine
|
|
|
|
N-methyl-d3-perfluoro-1-octanesulfonamidoacetic acid
|
|
|
|
NMDA Receptor 1, N1
|
|
|
|
NMDAR1/GluN1 Blocking Peptide
|
|
|
|
N-omega-CD3-Octadecanoyl disialoganglioside GD3 (NH4+ salt)
|
|
|
|
N-omega-CD3-Octadecanoyl-D-erythro-sphingosine
|
|
|
|
N-omega-CD3-Octadecanoyl-D-erythro-sphingosine-1-phosphate
|
|
|
|
N-Octadecanoyl-D35-psychosine, (perdeuterated, C18:0 fatty acid)
|
|
|
|
N-omega-CD3-Octadecanoyl-phytosphingosine
|
|
|
|
Normal sheep IgG from non-immunized animal: Protein G purified
|
|
|
|
Normal sheep serum from non-immunized animal
|
|
|
|
Nylon Syringe Filter, 0.10 μm, 13 mm, Nonsterile
|
|
|
|
Nylon Syringe Filter, 1 μm, 20 mm, Nonsterile
|
|
|
|
Nucleoprotein (N) of Novel Coronavirus SARS-CoV-2/ 2019-nCoV (human)
|
|
|
|
N-Tetracosanoyl-D-erythro-dihydrosphingosine
|
|
|
|
Nylon Syringe Filters, 10 μm, 25 mm, Nonsterile
|
|
|
|
NT-3 GMP, CF
|
|
|
|
Nylon Syringe Filter, 0.45 μm, 25 mm, Nonsterile
|
|
|
|
NPY Y2 Receptor-C/N Terminus
|
|
|
|
N-Ras Protein, wild-type (human recombinant with 6xHis-tag)
|
|
|
|
Occipital Lobe
|
|
|
|
Occludin, Human, pAb, 100 ug
|
|
|